Boulaiz, H.; Jiménez-MartÃnez, Y.; Franco-Montalbán, F.; Peña-MartÃn, J.; Conejo-GarcÃa, A.; Carrión, M.D.
Benzoxazine–Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action. Pharmaceutics 2025, 17, 1260.
https://doi.org/10.3390/pharmaceutics17101260
AMA Style
Boulaiz H, Jiménez-MartÃnez Y, Franco-Montalbán F, Peña-MartÃn J, Conejo-GarcÃa A, Carrión MD.
Benzoxazine–Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action. Pharmaceutics. 2025; 17(10):1260.
https://doi.org/10.3390/pharmaceutics17101260
Chicago/Turabian Style
Boulaiz, Houria, Yaiza Jiménez-MartÃnez, Francisco Franco-Montalbán, Jesús Peña-MartÃn, Ana Conejo-GarcÃa, and M. Dora Carrión.
2025. "Benzoxazine–Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action" Pharmaceutics 17, no. 10: 1260.
https://doi.org/10.3390/pharmaceutics17101260
APA Style
Boulaiz, H., Jiménez-MartÃnez, Y., Franco-Montalbán, F., Peña-MartÃn, J., Conejo-GarcÃa, A., & Carrión, M. D.
(2025). Benzoxazine–Purine Hybrids as Antiproliferative Agents: Rational Design and Divergent Mechanisms of Action. Pharmaceutics, 17(10), 1260.
https://doi.org/10.3390/pharmaceutics17101260